|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-8-2
|
|
pubmed:abstractText |
To evaluate the safety and effect on visual acuity of photodynamic therapy with verteporfin (Visudyne, Novartis AG) in patients with subfoveal choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0161-6420
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1499-505
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12153802-Adult,
pubmed-meshheading:12153802-Aged,
pubmed-meshheading:12153802-Choroidal Neovascularization,
pubmed-meshheading:12153802-Eye Infections, Fungal,
pubmed-meshheading:12153802-Female,
pubmed-meshheading:12153802-Fluorescein Angiography,
pubmed-meshheading:12153802-Fovea Centralis,
pubmed-meshheading:12153802-Histoplasmosis,
pubmed-meshheading:12153802-Humans,
pubmed-meshheading:12153802-Male,
pubmed-meshheading:12153802-Middle Aged,
pubmed-meshheading:12153802-Photochemotherapy,
pubmed-meshheading:12153802-Photosensitizing Agents,
pubmed-meshheading:12153802-Porphyrins,
pubmed-meshheading:12153802-Prospective Studies,
pubmed-meshheading:12153802-Retinal Diseases,
pubmed-meshheading:12153802-Safety,
pubmed-meshheading:12153802-Syndrome,
pubmed-meshheading:12153802-Visual Acuity
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
